Previous 10 | Next 10 |
HOUSTON and VANCOUVER , Feb. 27, 2020 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the votes on matters...
ESSA Pharma (NASDAQ: EPIX ): Q1 GAAP EPS of -$0.22 misses by $0.05 . More news on: ESSA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
VANCOUVER and HOUSTON, TX , Feb. 13, 2020 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financi...
HOUSTON and VANCOUVER , Feb. 10, 2020 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced today that several abstracts on ESSA's lead clinical candidate, EPI-7386, have...
ESSA Pharma (NASDAQ: EPIX ): Q4 GAAP EPS of -$0.07 beats by $0.11 . More news on: ESSA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019 Canada NewsWire VANCOUVER and HOUSTON, Dec. 19, 2019 VANCOUVER and HOUSTON , Dec. 19, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company")...
–Addition of Experienced Executive to Leadership Team– CAMBRIDGE, Mass. and MISSISSAUGA, Ontario, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Janpix, Inc., a privately-held biopharmaceutical company dedicated to the discovery and development of inhibitors/degraders of Signal Transduce...
Dover, Delaware--(Newsfile Corp. - November 11, 2019) - Encode Ideas, L.P. Initiates Research on ESSA Pharma, Inc. (NASDAQ: EPIX). The full research publication is available here and available on our website at www.encodelp.com . A summary follows: Encode Ideas, L.P., a healthcare focused ...
HOUSTON and VANCOUVER , Oct. 28, 2019 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today in Boston will present new preclinical data on ESSA's lead Investigational New D...
VANCOUVER and HOUSTON, TX , Oct. 18, 2019 /PRNewswire/ - ESSA Pharma Inc. (" ESSA " or the " Company ") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announces that Ari Brettman has been appointed ...
News, Short Squeeze, Breakout and More Instantly...
ESSA Pharma to Present at the JonesHealthcare Seaside Summit Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , July 8, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on de...
ESSA Pharma to Present at the Jefferies Global Healthcare Conference Canada NewsWire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , May 30, 2024 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focus...